- Filed
- Jul 1, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 4.96M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 2.55M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2025 | $954.84K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$10.71M |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $6.41M |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $7.46M |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $3.58M |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $5.19M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $372.56K |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $3.42M |
| Cash And Equivalents restated | Q2 2025 · Mar 31, 2024 | $640.88K |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $55.05M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $58.57M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $14.85M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $16.89M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $21.27M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $24.38M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $32.33M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $41.4M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $78.61M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $85.36M |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | −$0.23 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$1.59 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | −$0.23 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$1.59 |
| Sga Expense | Q2 2025 · Mar 31, 2025 | $1.2M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $1.84M |
| Rd Expense | Q2 2025 · Mar 31, 2025 | $389.57K |
| Rd Expense restated | Q2 2025 · Mar 31, 2024 | $395.44K |
| Net Income | Q2 2025 · Mar 31, 2025 | −$1.14M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$4.05M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$1.04M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$1.77M |
| Gross Profit | Q2 2025 · Mar 31, 2025 | $671.47K |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $608.88K |
| Cost Of Revenue | Q2 2025 · Mar 31, 2025 | $5.89M |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $6.2M |
| Revenue | Q2 2025 · Mar 31, 2025 | $6.57M |
| Revenue | Q2 2025 · Mar 31, 2024 | $6.8M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $1.56M |